Larry Scher (New York, USA) interviews John Aruny (Orangeburg, USA) and Stephen Hohmann (Dallas, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about the use of drug-eluting devices in contemporary haemodialysis access practice.
Scher says the topic is itself “controversial” as the use of drug-eluting stents and balloons in the lower extremities has suggested an increased mortality risk.
Aruny says the initial results of drug-eluting trials were “exciting” and showed improved patency but that the mortality signal has meant the field is “operating under a bit of a cloud”. He adds that it is important now to have separate trials that look at the use of drug-eluting devices in haemodialysis patients.
Hohmann adds that a big focus at the moment relates to “cost” and if drug-coated balloons could decrease the number of interventions it would be “a game-changer” in this regard. Both Aruny and Hohmann recognise the potential of the practice and argue that vessel preparation is the “key to success” in using drug-eluting technology.
Subscribe to receive BLearning videos here: https://blearning.net/registration/